The goal of our lab is to contribute to the improvement of treatments for patients with hematologcial malignancies. Research strategies focus on identifying novel vulnerabilities and treatment targets in myeloid disorders (AML, MDS, MPNs) and translating those into new therapy approaches.
The challenge is that many molecular aberrations in cancer may or may not be optimal therapy targets. While it is important to understand the disease pathobiology it is similarly important to identify the crucial vulnerabilities in leukemia cells/genomes that lead to cell death/killing when inhibited.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.